Share This

Related Topics News -

     
 Title only   |   Print 
     
遠大醫藥取得創新眼用製劑 「TP-03」大中華區獨家授權 首付款1,500萬美元

2024-03-27T  
遠大醫藥治療胃腸胰腺神經內分泌腫瘤新藥獲批內地三期臨床

2024-03-25T  
《公司業績》遠大醫藥全年純利18.8億元跌9.6% 派末期息26仙

2024-03-20T  
遠大醫藥用於延緩兒童近視新藥臨床試驗獲批

2024-03-07T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.